290 related articles for article (PubMed ID: 21986587)
1. Synthesis and anti-tumor activities of N'-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives.
Lou J; Liu Z; Li Y; Zhou M; Zhang Z; Zheng S; Wang R; Li J
Bioorg Med Chem Lett; 2011 Nov; 21(22):6662-6. PubMed ID: 21986587
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: synthesis, biological evaluation, and structure-activity relationships.
Horiuchi T; Chiba J; Uoto K; Soga T
Bioorg Med Chem Lett; 2009 Jan; 19(2):305-8. PubMed ID: 19091560
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1-CDK4: synthesis, biological evaluation and structure-activity relationships. Part 2.
Horiuchi T; Nagata M; Kitagawa M; Akahane K; Uoto K
Bioorg Med Chem; 2009 Dec; 17(23):7850-60. PubMed ID: 19889545
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducers.
Kemnitzer W; Sirisoma N; May C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Jul; 19(13):3536-40. PubMed ID: 19464890
[TBL] [Abstract][Full Text] [Related]
6. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-tumor evaluation of novel hydrazide and hydrazide-hydrazone derivatives.
Wardakhan WW; El-Sayed NN; Mohareb RM
Acta Pharm; 2013 Mar; 63(1):45-57. PubMed ID: 23482312
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationship of novel substituted 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer agents.
Raju BC; Rao RN; Suman P; Yogeeswari P; Sriram D; Shaik TB; Kalivendi SV
Bioorg Med Chem Lett; 2011 May; 21(10):2855-9. PubMed ID: 21507635
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 2-[2-(phenylthiomethyl)-1H-benzo[d] imidazol-1-yl)acetohydrazide derivatives as antitumor agents.
Liu T; Sun C; Xing X; Jing L; Tan R; Luo Y; Huang W; Song H; Li Z; Zhao Y
Bioorg Med Chem Lett; 2012 May; 22(9):3122-5. PubMed ID: 22483608
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
Li ZH; Yang DX; Geng PF; Zhang J; Wei HM; Hu B; Guo Q; Zhang XH; Guo WG; Zhao B; Yu B; Ma LY; Liu HM
Eur J Med Chem; 2016 Nov; 124():967-980. PubMed ID: 27771599
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics.
Easmon J; Pürstinger G; Thies KS; Heinisch G; Hofmann J
J Med Chem; 2006 Oct; 49(21):6343-50. PubMed ID: 17034140
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents.
Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; İşcan G; Kaplancıklı ZA
Eur J Med Chem; 2012 Dec; 58():299-307. PubMed ID: 23142671
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
14. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer activities of 5-acyl-6-[2-hydroxy/benzyloxy-3-(amino)-propylamino]-1,3-dialkyl-1H-pyrimidin-2,4-diones.
Singh P; Paul K
Bioorg Med Chem; 2006 Dec; 14(24):8622-5. PubMed ID: 16949293
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines.
Li J; Zhao YF; Zhao XL; Yuan XY; Gong P
Arch Pharm (Weinheim); 2006 Nov; 339(11):593-7. PubMed ID: 17036367
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel Thieno[2,3-d]pyrimidin-4-yl hydrazone-based cyclin-dependent kinase 4 inhibitors: synthesis, biological evaluation and structure-activity relationships.
Horiuchi T; Takeda Y; Haginoya N; Miyazaki M; Nagata M; Kitagawa M; Akahane K; Uoto K
Chem Pharm Bull (Tokyo); 2011; 59(8):991-1002. PubMed ID: 21804244
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line.
Hassan GS; Kadry HH; Abou-Seri SM; Ali MM; Mahmoud AE
Bioorg Med Chem; 2011 Nov; 19(22):6808-17. PubMed ID: 22000322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]